Cargando…
Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study
BACKGROUND: Nonpersistence in anticoagulation therapy is common and associated with undesirable clinical outcomes in patients with venous thromboembolism (VTE). METHODS: We investigated preceding clinical events of treatment nonpersistence (e.g., switching, discontinuing, or restarting) in VTE patie...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660092/ https://www.ncbi.nlm.nih.gov/pubmed/37882319 http://dx.doi.org/10.1002/cam4.6626 |
_version_ | 1785137688645468160 |
---|---|
author | Yoon, Dongwon Jeong, Han Eol Choi, Songhwa Lee, Daye Shin, Ju‐Young Bang, Soo‐Mee |
author_facet | Yoon, Dongwon Jeong, Han Eol Choi, Songhwa Lee, Daye Shin, Ju‐Young Bang, Soo‐Mee |
author_sort | Yoon, Dongwon |
collection | PubMed |
description | BACKGROUND: Nonpersistence in anticoagulation therapy is common and associated with undesirable clinical outcomes in patients with venous thromboembolism (VTE). METHODS: We investigated preceding clinical events of treatment nonpersistence (e.g., switching, discontinuing, or restarting) in VTE patients with and without active cancer using Korean claims database. RESULTS: Clinically significant events including thromboembolic events, hepatic function change and surgery preceded treatment nonpersistence, but heterogeneous distributions of clinical events were observed in the presence of active cancer. Patients with active cancer had a low rate of clinical events preceding treatment nonpersistence, and new active cancer diagnosis in the nonactive cancer group was most common before the switch to parenteral anticoagulants from warfarin or non‐vitamin K antagonist oral anticoagulants (NOACs). CONCLUSION: These findings suggest that clinically significant events can precede treatment nonpersistence and largely paralleled current guidelines for patients with VTE, whereas heterogeneous distributions of clinical events were observed in the presence of active cancer. |
format | Online Article Text |
id | pubmed-10660092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106600922023-10-26 Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study Yoon, Dongwon Jeong, Han Eol Choi, Songhwa Lee, Daye Shin, Ju‐Young Bang, Soo‐Mee Cancer Med BRIEF COMMUNICATION BACKGROUND: Nonpersistence in anticoagulation therapy is common and associated with undesirable clinical outcomes in patients with venous thromboembolism (VTE). METHODS: We investigated preceding clinical events of treatment nonpersistence (e.g., switching, discontinuing, or restarting) in VTE patients with and without active cancer using Korean claims database. RESULTS: Clinically significant events including thromboembolic events, hepatic function change and surgery preceded treatment nonpersistence, but heterogeneous distributions of clinical events were observed in the presence of active cancer. Patients with active cancer had a low rate of clinical events preceding treatment nonpersistence, and new active cancer diagnosis in the nonactive cancer group was most common before the switch to parenteral anticoagulants from warfarin or non‐vitamin K antagonist oral anticoagulants (NOACs). CONCLUSION: These findings suggest that clinically significant events can precede treatment nonpersistence and largely paralleled current guidelines for patients with VTE, whereas heterogeneous distributions of clinical events were observed in the presence of active cancer. John Wiley and Sons Inc. 2023-10-26 /pmc/articles/PMC10660092/ /pubmed/37882319 http://dx.doi.org/10.1002/cam4.6626 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | BRIEF COMMUNICATION Yoon, Dongwon Jeong, Han Eol Choi, Songhwa Lee, Daye Shin, Ju‐Young Bang, Soo‐Mee Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study |
title | Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study |
title_full | Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study |
title_fullStr | Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study |
title_full_unstemmed | Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study |
title_short | Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study |
title_sort | heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: a nationwide cohort study |
topic | BRIEF COMMUNICATION |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660092/ https://www.ncbi.nlm.nih.gov/pubmed/37882319 http://dx.doi.org/10.1002/cam4.6626 |
work_keys_str_mv | AT yoondongwon heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy AT jeonghaneol heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy AT choisonghwa heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy AT leedaye heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy AT shinjuyoung heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy AT bangsoomee heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy |